Prosecution Insights
Last updated: October 04, 2026

Touchlight IP Limited

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Touchlight IP Limited currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is concentrated under 1 distinct examiner and 1 distinct art unit, indicating a highly focused prosecution footprint at this stage of the company's patent filings. Because the entire active workload is confined to 1 administrative unit, the company's current interactions with the patent office are centralized, which allows for the tracking of deadlines and examiner communications within this specific portfolio to remain focused.

The busiest examiner for the portfolio is YAMASAKI, ROBERT J, who is responsible for 1 busiest examiner pending office action. Because the total pending office actions and the busiest examiner pending count both equal 1, this specific examiner handles the entirety of the company's current workload before the office. This relationship between the total actions and those assigned to the busiest examiner means that the prosecution strategy for the company's pending matters is currently dependent on the review of 1 individual. For practitioners, this concentration suggests that understanding the specific preferences and historical trends of YAMASAKI, ROBERT J is a primary consideration, as there are no other distinct examiners or art units currently influencing the portfolio's pending outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YAMASAKI, ROBERT J 1 67.6% +43.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17799353 DNA SYNTHESIS YIELD IMPROVEMENTS YAMASAKI, ROBERT J —

Top Art Units

Art UnitApps
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17799353 DNA SYNTHESIS YIELD IMPROVEMENTS YAMASAKI, ROBERT J 1657 §103§112DP Non-Final OA — Pending Aug 12, 2022

Managing Touchlight IP Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month